Clinical Trial Update: A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection [Phase 3]

View source ↗

Summary

Phase 3, multi-center, single-arm trial evaluating RBX2660 delivered by colonoscopy in adults with recurrent Clostridioides difficile infection has completed an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• RBX2660 (RBX2660)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Clostridium Difficile Infection Recurrence | Phase 3 | Status: COMPLETED | Results posted: 2026-04-24